Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) had its target price increased by research analysts at Deutsche Bank Aktiengesellschaft from $36.00 to $37.00 in a report issued on Monday, Benzinga reports. The firm currently has a “hold” rating on the stock. Deutsche Bank Aktiengesellschaft’s target price suggests a potential downside of 2.19% from the stock’s previous close.
A number of other research analysts also recently issued reports on the company. BNP Paribas assumed coverage on Keurig Dr Pepper in a report on Monday, June 24th. They set a “neutral” rating and a $36.00 price objective for the company. Evercore ISI upgraded Keurig Dr Pepper to a “hold” rating in a research note on Thursday, September 5th. Wells Fargo & Company raised their price target on Keurig Dr Pepper from $39.00 to $41.00 and gave the company an “overweight” rating in a research note on Wednesday, June 5th. Barclays decreased their price target on Keurig Dr Pepper from $38.00 to $37.00 and set an “overweight” rating for the company in a research note on Friday, July 19th. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $41.00 price target on shares of Keurig Dr Pepper in a research note on Friday, July 26th. Eight equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat.com, Keurig Dr Pepper presently has an average rating of “Moderate Buy” and an average price target of $37.20.
Check Out Our Latest Research Report on Keurig Dr Pepper
Keurig Dr Pepper Trading Down 0.5 %
Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) last released its quarterly earnings results on Thursday, July 25th. The company reported $0.45 EPS for the quarter, hitting analysts’ consensus estimates of $0.45. The company had revenue of $3.92 billion for the quarter, compared to analyst estimates of $3.91 billion. Keurig Dr Pepper had a return on equity of 10.32% and a net margin of 14.47%. Keurig Dr Pepper’s revenue was up 3.5% compared to the same quarter last year. During the same quarter last year, the firm posted $0.42 earnings per share. On average, equities analysts expect that Keurig Dr Pepper will post 1.92 earnings per share for the current year.
Hedge Funds Weigh In On Keurig Dr Pepper
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Sanctuary Advisors LLC acquired a new position in shares of Keurig Dr Pepper during the 2nd quarter worth $2,564,000. Heritage Oak Wealth Advisors LLC acquired a new position in shares of Keurig Dr Pepper during the 2nd quarter worth $208,000. Aristides Capital LLC acquired a new position in shares of Keurig Dr Pepper during the 2nd quarter worth $501,000. Truist Financial Corp raised its holdings in shares of Keurig Dr Pepper by 169.3% during the 2nd quarter. Truist Financial Corp now owns 238,251 shares of the company’s stock worth $7,958,000 after buying an additional 149,776 shares in the last quarter. Finally, Kimelman & Baird LLC acquired a new position in shares of Keurig Dr Pepper during the 2nd quarter worth $127,000. 85.23% of the stock is owned by institutional investors and hedge funds.
About Keurig Dr Pepper
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
Read More
- Five stocks we like better than Keurig Dr Pepper
- NYSE Stocks Give Investors a Variety of Quality Options
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- 10 Best Airline Stocks to Buy
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- How to Read Stock Charts for Beginners
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.